-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
5 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$138,069
CytomX Therapeutics, Inc. Insider Transactions
CytomX Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
ROWLAND LLOYD A
General Counsel |
Sell | 5,268 @ $2.09 | $10,986 | 117,728 | 03/19/2024 | 03/21/2024 | |
|
McCarthy Sean A.
CEO |
Sell | 20,223 @ $2.09 | $42,175 | 524,481 | 03/19/2024 | 03/21/2024 | |
|
Ogden Christopher
SVP, Finance and Accounting |
Sell | 2,971 @ $2.09 | $6,196 | 85,686 | 03/19/2024 | 03/21/2024 | |
|
BELVIN MARCIA
SVP, Chief Scientific Officer |
Sell | 12,795 @ $2.09 | $26,684 | 168,579 | 03/19/2024 | 03/21/2024 | |
|
Landau Jeffrey B
Chief Business Officer |
Sell | 6,562 @ $2.09 | $13,685 | 110,060 | 03/19/2024 | 03/21/2024 | |
|
McCarthy Sean A.
CEO |
Sell | 13,551 @ $1.38 | $18,710 | 454,704 | 12/20/2023 | 12/22/2023 | |
|
BELVIN MARCIA
SVP, Chief Scientific Officer |
Sell | 4,077 @ $1.38 | $5,628 | 155,124 | 12/20/2023 | 12/22/2023 | |
|
Landau Jeffrey B
Chief Business Officer |
Sell | 4,077 @ $1.38 | $5,628 | 86,622 | 12/20/2023 | 12/22/2023 | |
|
ROWLAND LLOYD A
General Counsel |
Sell | 4,077 @ $1.38 | $5,629 | 97,996 | 12/20/2023 | 12/22/2023 | |
|
Ogden Christopher
SVP, Finance and Accounting |
Sell | 1,990 @ $1.38 | $2,747 | 48,657 | 12/20/2023 | 12/22/2023 | |
|
BELVIN MARCIA
SVP, Chief Scientific Officer |
Sell | 4,119 @ $1.30 | $5,356 | 147,951 | 09/22/2023 | 09/22/2023 | |
|
Landau Jeffrey B
Chief Business Officer |
Sell | 4,119 @ $1.30 | $5,356 | 76,379 | 09/22/2023 | 09/22/2023 | |
|
McCarthy Sean A.
CEO |
Sell | 14,601 @ $1.30 | $18,987 | 430,755 | 09/22/2023 | 09/22/2023 | |
|
ROWLAND LLOYD A
General Counsel |
Sell | 5,486 @ $1.30 | $7,135 | 80,609 | 09/22/2023 | 09/22/2023 | |
|
Jones Elaine V
Director |
Buy | 5,000 @ $1.55 | $7,750 | 5,142 | 03/29/2023 | 03/31/2023 | |
|
Ogden Christopher
SVP, Finance and Accounting |
Sell | 516 @ $1.98 | $1,021 | 37,772 | 03/16/2023 | 03/20/2023 | |
|
McCarthy Sean A.
CEO |
Sell | 7,121 @ $1.88 | $13,391 | 388,821 | 03/16/2023 | 03/20/2023 | |
|
Campoy Carlos
CFO |
Sell | 1,748 @ $1.98 | $3,459 | 38,224 | 03/16/2023 | 03/20/2023 | |
|
ROWLAND LLOYD A
General Counsel |
Sell | 2,037 @ $1.98 | $4,031 | 71,095 | 03/16/2023 | 03/20/2023 | |
|
Landau Jeffrey B
CFO |
Sell | 1,477 @ $1.98 | $2,923 | 69,248 | 03/16/2023 | 03/20/2023 |
CytomX Therapeutics, Inc. Frequently Asked Questions
-
Who is on CytomX Therapeutics, Inc.'s Insider Roster?
The list of insiders at CytomX Therapeutics, Inc. includes Ogden Christopher, ROWLAND LLOYD A, Landau Jeffrey B, BELVIN MARCIA, McCarthy Sean A..
-
How much insider selling is happening at CytomX Therapeutics, Inc.?
Insiders have sold a total of 75,591 CytomX Therapeutics, Inc. shares in the last 12 months for a total of 138,069 sold.
-
Which CytomX Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold CytomX Therapeutics, Inc. shares in the last 12 months: Ogden Christopher ($8,943), ROWLAND LLOYD A ($16,616), Landau Jeffrey B ($19,313), BELVIN MARCIA ($32,312), McCarthy Sean A. ($60,885),